LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $854,000 | +4.1% | 8,588 | -0.2% | 0.01% | -12.5% |
Q3 2020 | $820,000 | -16.7% | 8,605 | -2.2% | 0.02% | -20.0% |
Q2 2020 | $984,000 | +54.2% | 8,795 | +0.2% | 0.02% | +33.3% |
Q1 2020 | $638,000 | -34.5% | 8,779 | -6.0% | 0.02% | -21.1% |
Q4 2019 | $974,000 | -1.8% | 9,342 | -6.3% | 0.02% | -9.5% |
Q3 2019 | $992,000 | -16.8% | 9,970 | -4.6% | 0.02% | -16.0% |
Q2 2019 | $1,192,000 | -12.8% | 10,446 | -3.9% | 0.02% | -10.7% |
Q1 2019 | $1,367,000 | -9.5% | 10,872 | -2.3% | 0.03% | -26.3% |
Q4 2018 | $1,511,000 | -11.9% | 11,133 | +78.0% | 0.04% | +5.6% |
Q3 2018 | $1,716,000 | +34.5% | 6,253 | +1.6% | 0.04% | +24.1% |
Q2 2018 | $1,276,000 | +32.0% | 6,157 | +5.2% | 0.03% | +26.1% |
Q1 2018 | $967,000 | +28.6% | 5,855 | +6.7% | 0.02% | +35.3% |
Q4 2017 | $752,000 | +4.3% | 5,489 | +3.6% | 0.02% | -5.6% |
Q3 2017 | $721,000 | +26.5% | 5,298 | +12.8% | 0.02% | +28.6% |
Q2 2017 | $570,000 | +21.3% | 4,695 | +5.8% | 0.01% | +16.7% |
Q1 2017 | $470,000 | +11.4% | 4,438 | +6.8% | 0.01% | +9.1% |
Q4 2016 | $422,000 | +5.8% | 4,156 | +6.4% | 0.01% | 0.0% |
Q3 2016 | $399,000 | -9.7% | 3,907 | +5.5% | 0.01% | -15.4% |
Q2 2016 | $442,000 | +28.1% | 3,704 | +14.9% | 0.01% | +18.2% |
Q1 2016 | $345,000 | +8.8% | 3,223 | +10.3% | 0.01% | +10.0% |
Q4 2015 | $317,000 | +39.0% | 2,923 | +9.8% | 0.01% | +25.0% |
Q3 2015 | $228,000 | -8.4% | 2,662 | +7.7% | 0.01% | 0.0% |
Q2 2015 | $249,000 | +36.8% | 2,472 | +4.5% | 0.01% | +33.3% |
Q1 2015 | $182,000 | +45.6% | 2,366 | +0.9% | 0.01% | +500.0% |
Q4 2014 | $125,000 | +12.6% | 2,344 | -0.7% | 0.00% | 0.0% |
Q3 2014 | $111,000 | -31.5% | 2,360 | -9.4% | 0.00% | 0.0% |
Q2 2014 | $162,000 | -4.1% | 2,605 | +3.5% | 0.00% | 0.0% |
Q1 2014 | $169,000 | -1.2% | 2,517 | -22.5% | 0.00% | 0.0% |
Q4 2013 | $171,000 | – | 3,246 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |